cytarabine has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boogaerts, M; Verhoef, G | 1 |
1 other study(ies) available for cytarabine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Treatment with granulocyte-macrophage colony stimulating factor and the adult respiratory distress syndrome.
Topics: Antigens, Differentiation; CD11 Antigens; CD18 Antigens; Cell Adhesion; Cytarabine; Dose-Response Relationship, Drug; Endothelium; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lung; Male; Middle Aged; Neutrophils; Platelet Activating Factor; Receptors, Leukocyte-Adhesion; Respiratory Distress Syndrome; Superoxides; Tumor Necrosis Factor-alpha | 1991 |